Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Germ Cell and Embryonal × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

pralsetinib 2 pembrolizumab 2 Brentuximab Vedotin 2 Bevacizumab 2 ribociclib 1 fosaprepitant 1 Sunitinib 1 Sirolimus 1 Radiotherapy, Image-Guided 1 Plicamycin 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Genistein 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Dexamethasone 1 Cisplatin 1 Carboplatin 1 Aprepitant 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡